Two U.S. companies say they will carry out an observational study to evaluate the impact of CBD on sleep.
Prospect Farms, Prospect, Maine, and Radicle Science, San Diego, California, say they will check duration and quality of sleep when Prospect Farms’ Dream Tincture CBD is administered to participating subjects nightly over the course of a month.
Radicle’s scientific team includes doctors, researchers, biostatisticians and data scientists at institutions including UCLA, UC San Diego, Scripps Sleep Center, Johns Hopkins and the University of Washington. The company said it is focused on the need for research and evidence for natural health products.
Research team
The initiative will be led by Radicle Science’s Jeffrey Chen, founder and former director of the UCLA Cannabis Research Initiative, and Pelin Thorogood, president and co-founder of the Wholistic Research and Education Foundation.
Prospect Farms makes its Dream Tincture from start to finish on a vertically integrated farm. The product includes full-spectrum hemp extract from organically grown hemp, a blend of naturally derived terpenes including Linalool (a component of lavender) and Myrcene, and an antioxidant of carrier oils including avocado, olive and grape seed oils.
